Envigo has appointed Adrian Hardy as president and chief executive officer, effective July 1, 2016, and he will also join the company’s board of directors. Dr. Hardy joined Envigo in 2002 and has held various roles of increasing responsibility in sales, strategic marketing and operations, most recently serving as chief operating officer.

In related moves, Brian Cass, the previous chief executive, will become executive chairman, and Andrew Baker, the previous chairman, will become chairman emeritus and remain a board member.
 
“In the 18 years that I have had the privilege to lead our company I have witnessed great, and positive changes within life science research and in our company,” said Mr. Cass. “Envigo has truly come of age and is now a crucial partner to our customers in the conduct of their research and the development of their life-changing products. I am enthusiastic that the skills, experience, and passion that Adrian brings to the role of chief executive officer positions him to successfully lead Envigo to the next level in its development.”